Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
LGD-3303 is used in methods reducing mammographic breast density and/or breast cancer risk comprising the administration of an effective administration of an androgenic agent and an effective amt. of an aromatase inhibitor. LGD-3303 is also used in combination with anti-TWEAK antibodies for treating muscle atrophy.
?您的位置：
